InvestorsHub Logo
Followers 13
Posts 109
Boards Moderated 0
Alias Born 11/16/2019

Re: None

Tuesday, 09/21/2021 10:39:19 AM

Tuesday, September 21, 2021 10:39:19 AM

Post# of 43832
Article highlights two more trials that bit the dust in Head & Neck Cancer, when assessing overall survival. Multikine did something truly amazing, which is clearly not well understood by the market.

But it will be!

https://www.fiercepharma.com/pharma/bristol-myers-opdivo-yervoy-pfizer-merck-kgaa-s-bavencio-hit-walls-head-and-neck-cancer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News